Results
eNauka >
Results >
Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized double-blind safety and efficacy trial.
Title: | Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized double-blind safety and efficacy trial. | Authors: | Rigas, James R; Schuster, Michael W; Orlov, Sergey V; Milovanovic, Branislav M; Prabhash, Kumar; Smith, Jeffrey T | Issue Date: | 2010 | Publication: | JOURNAL OF CLINICAL ONCOLOGY | ISSN: | 0732-183X![]() ![]() |
Type: | Conference Paper | Collation: | vol. 28 br. 15 | WoS-ID: | 000208852005002 | URI: | https://enauka.gov.rs/handle/123456789/801173 | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.